IGKV1D-22 and Hyperglycemia: Indeed, we have previously shown that blocking S100A8/A9 signaling, using a small molecular inhibitor ABR-215757 (Paquinimod), in STZ-diabetic mice prevents hyperglycemia-induced atherogenesis and reduces plaque macrophage content (Kraakman et al., 2017).